The primary objective is to assess the effectiveness of exposure in vivo directly following implementation in adults with chronic musculoskeletal pain (CMSP). Secondary objectives are to assess procedural fidelity and its progression directly…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
chronische pijn
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Accomplishment of patient*specific goals and pain-related disability
(activities and participation).
Secondary outcome
Pain and fatigue, illness perception and coping, patients rating of improvement
and satisfaction, retention, physical functioning, emotional functioning,
symptoms and adverse events, and medical consumption. Procedural fidelity is
also a secondary outcome.
Background summary
Various studies have assessed exposure in vivo and, generally, found positive
effects. In order to increase the impact of the intervention, an important next
step is to investigate the implementation of the protocol in other
rehabilitation facilities. Since procedural fidelity is a prerequisite for
effectiveness, it is important to ascertain to what extent interventionists,
after following the training, deliver the intervention as intended. Moreover,
it is of interest to know whether the effectiveness holds directly following
implementation in a new setting.
Study objective
The primary objective is to assess the effectiveness of exposure in vivo
directly following implementation in adults with chronic musculoskeletal pain
(CMSP). Secondary objectives are to assess procedural fidelity and its
progression directly following the implementation *of exposure in vivo in a
rehabilitation center; and to assess whether catastrophizing is a mediator in
the potential effectiveness of exposure in vivo in adults with chronic
musculoskeletal pain. *
Study design
A replicated randomized AB phase single-case experimental design (SCED) with
follow-up.
Intervention
Exposure in vivo treatment: a 12-week module including 16 treatment sessions of
one hour each.
Study burden and risks
Participants will complete 11 daily questions for 14-18 weeks (diary). In
addition, audio recordings are made of all treatment sessions.
Dokter Stolteweg 48
Zwolle 8025 AX
NL
Dokter Stolteweg 48
Zwolle 8025 AX
NL
Listed location countries
Age
Inclusion criteria
- chronic musculoskeletal pain consisting at least three months and diagnosed
by a general practitioner or medical specialist;
- aged >= 18 years; and
- an indication for the exposure in vivo treatment given by an
interdisciplinary team including a physiatrist, physical therapist, and
psychologist.
Exclusion criteria
Any of the contra-indications described by Verbunt et al., for instance, an
unstable medical, emotional-personal and/or social situation.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL76656.075.21 |